Free case Evaluation Get startedbutton-icon

Zantac contains the substance NDMA which has been linked to a number of cancers including bladder cancer, brain cancer, breast cancer, esophageal/nasal/throat cancer, intestinal cancer, kidney cancer, liver cancer, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, stomach cancer, testicular cancer, thyroid cancer, uterine cancer, and other cancers.

Anyone who previously took Zantac & has been subsequently diagnosed with cancer may qualify to participate in the Zantac Lawsuit.

Yes. The Zantac class action lawsuit was filed on behalf of individuals who used Zantac but were not diagnosed with cancer.

Many individual Zantac cancer lawsuits are being consolidated into a multidistrict litigation filed against Zantac manufacturer Sanofi in the Southern District of Florida.

The Zantac class-action has been consolidated in the Southern District of Florida.

The FDA issued a recall of all prescription and over-the-counter versions of Zantac in April 2020.

related areas of practice

What is Zantac?

Zantac is the trade name for Ranitidine, a popular heartburn medication that reduces the body’s production of stomach acid. The medication is commonly used to treat and prevent ulcers of the stomach and intestines as well as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, peptic ulcer disease, acid indigestion, and heartburn.

Zantac is available both over-the-counter and by prescription. Ranitidine belongs to the h2 (histamine-2) blockers class of drugs. OTC Zantac is most commonly used to relieve and prevent heartburn, while the prescription-strength drug is used to prevent more serious ulcers and conditions. The drug came into commercial use in 1981 and is now the 50th most prescribed medication in the United States.

 

Zantac Products & Generic Products Containing Ranitidine

These are the most common Zantac products and generic Zantac products containing ranitidine:

  • Zantac 150 Tablets
  • Zantac 150 Maximum Strength
  • Zantac 150 Maximum Strength Cool Mint
  • Zantac 75 Tablets
  • Wal-Zan 150
  • Wal-Zan 75
  • Heartburn Relief
  • Acid Reducer
  • Acid Control

 

FDA Warning - Ranitidine Containing NDMA Poses Cancer Risk

The U.S. Food and Drug Administration (FDA) reported an advisory on September 13, 2019, after discovering the carcinogenic contaminant NDMA in ranitidine, the active ingredient in Zantac, at levels between 3,000 to 26,000 times higher than FDA approved standards.

The FDA acceptable threshold of daily NDMA intake is set at below 100 nanograms. The plaintiffs cited a study that claims that a 150-milligram pill of Zantac contains over 2.5 million nanograms of NDMA. Over-the-counter Zantac is typically sold in 150-milligram tablets; the recommended dosage to treat peptic ulcer disease for adults is 300 milligrams a night for four to eight weeks.

Plaintiffs allege that Sanofi and Boehringer Ingleham knew the risks of NDMA formation in ranitidine and did not alert the public through the drug’s label or through any other means. Several published studies have shown that ranitidine users have a 400-fold increase of NDMA concentration in their urine. The suit attests that had consumers known the risks, they would not have purchased or consumed ranitidine.

 

Zantac Cancer Risk

NDMA, n-nitrosodimethylamine, is a potential hepatotoxic, and exposure has been linked to numerous complications and symptoms ranging from bladder cancer, stomach cancer, liver fibrosis and scarring, and tumors in the liver, kidneys, and lungs. Other symptoms of NDMA exposure include headaches, fever, nausea, jaundice, vomiting, abdominal cramps, enlarged liver, dizziness, and reduced function of the liver, kidneys, and lungs. The World Health Organization described NDMA as a chemical that is “clearly carcinogenic.”

The U.S. Food and Drug Administration is working alongside regulators and industry partners to discover the source of impurities in ranitidine. The FDA is examining ranitidine NDMA levels and evaluating the potential risk to patients. The investigation is ongoing, and the agency plans to take appropriate measures.

 

What Kind of Cancer Does Zantac Cause?

Plaintiffs in the Zantac class-action lawsuit have a variety of cancers, including:

  • Bladder Cancer
  • Brain Cancer
  • Breast Cancer
  • Esophageal/Nasal/Throat Cancer
  • Intestinal Cancer
  • Kidney Cancer
  • Liver Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Uterine Cancer
  • Other Cancers

 

Zantac Recall

The FDA issued a recall of all prescription and over-the-counter versions of Zantac in April 2020.

After determining the levels of NDMA to be dangerous to consumers, the FDA called for patients to stop taking ranitidine and the agency has requested that the manufacturers recall the product and discontinue production of both Zantac and generic Zantac drugs.

Prior to this decision, some companies such as CVS, Walmart, and Sandoz have chosen to voluntarily suspend the sales of Zantac while waiting for results from ongoing tests and research.

Class-Action Lawsuit

The makers of Zantac, a popular over-the-counter and prescription heartburn medication, are facing a Zantac class-action lawsuit claiming the drug contains unsafe levels of the cancer-causing substance N-Nitrosodimethylamine (NDMA).

The U.S. Food and Drug Administration (FDA) reported an advisory on September 13, 2019, after discovering the carcinogenic contaminant NDMA in ranitidine, the active ingredient in Zantac, at levels between 3,000 to 26,000 times higher than FDA approved standards.

NDMA is a potential hepatotoxic, and exposure has been linked to numerous complications and symptoms ranging from bladder cancer, stomach cancer, liver fibrosis and scarring, and tumors in the liver, kidneys, and lungs. Other symptoms of NDMA exposure include headaches, fever, nausea, jaundice, vomiting, abdominal cramps, enlarged living, dizziness, and reduced function of the liver, kidneys, and lungs.

Plaintiffs accuse drugmakers Sanofi and Boehringer Ingelheim of manufacturing and marketing a medication they knew, or should have known, to be contaminated with the cancer-causing chemical without disclosing the risks to consumers or the government.

a Zantac class-action lawsuit has been filed against the manufacturers for concealing adverse health risks associated with Zantac that led plaintiffs to suffer serious injury and death.

 

NOTICE: TorHoerman Law is not involved in the Zantac class-action lawsuit.

 

Lawsuit Alleges NDMA in Zantac Increased Cancer Risks

The makers of Zantac, a popular heartburn medication, are facing a Zantac cancer lawsuit claiming the drug contains unsafe levels of the cancer-causing substance N-Nitrosodimethylamine (NDMA) which caused plaintiffs to develop cancer.

Plaintiffs accuse drugmakers Sanofi and Boehringer Ingelheim of manufacturing and marketing a medication they knew, or should have known, to be contaminated with the cancer-causing chemical without disclosing the risks to consumers or the government. The manufacturer’s failure to warn directly lead to plaintiffs developing a number of life-threatening types of cancer.

 

Notice: TorHoerman Law is involved in the Zantac Cancer Lawsuit. Our firm is currently accepting new clients for the Zantac Lawsuit. If you believe that you have a case, contact TorHoerman Law for a free, no-obligation case consultation with an experienced Zantac Lawyer. You can also use our chatbot to receive a free, instant online case evaluation right now.

 

Filing a Zantac Lawsuit

Zantac cancer lawsuits have been filed claiming that Zantac containing NDMA caused plaintiffs to develop cancer, which was not a potential side effect listed on the Zantac warning label.

Before filing a  Zantac lawsuit, you should familiarize yourself with the steps of the civil litigation process so that you are aware of the process of a Zantac lawsuit.

You should also do everything possible to mitigate your injuries – this includes discontinuing Zantac usage, seeking proper medical care, following the doctor’s orders, and doing everything in your power to minimize the costs and losses associated with any injuries that you have incurred.

The first step in a Zantac lawsuit is hiring a personal injury attorney who has experience handling bad drug lawsuits. In the unfortunate event that you are representing a loved one who has died as a result of injuries from Zantac, you may need to consult with a wrongful death attorney who has knowledge of the Zantac lawsuit.

Your Zantac lawyer will prove that liability for your injuries falls on the manufacture using evidence to establish that you incurred losses and or injuries due to Zantac.

This evidence will help to prove the total cost of losses that you endured as a result of your injury, also known as your damages. In many personal injury lawsuits, the injured party will choose to file for both compensatory damages and punitive damages. After assessing all damages that you incurred, your Zantac attorney will file a complaint demanding compensation to repay your damages.

 

Zantac Cancer Lawsuit vs Zantac Class-Action Lawsuit

Which type of Zantac Lawsuit should you file?

If you took Zantac consistently and did not develop cancer, but were unaware of the cancer risks associated with Zantac, you may be eligible to participate in the Zantac class-action lawsuit.

The Zantac class-action lawsuit will likely compensate a percentage of the money you paid over time for Zantac products.

The award will be split evenly amongst class members

If you took Zantac and were subsequently  diagnosed with cancer, you may qualify for a Zantac cancer lawsuit.

The Zantac cancer lawsuit will compensate a percentage of the total damages that you incurred as a result of your cancer diagnosis including but not limited to: medical bills, lost income, future medical bills, future lost income, pain & suffering, loss of enjoyment of life, loss of life, and other losses.

The award will reflect your personal losses.

Do I Qualify For the Zantac Cancer Lawsuit?

If you were diagnosed with cancer and took Zantac regularly prior to the diagnosis, contact a Zantac cancer lawyer to discuss your legal options, including filing a Zantac cancer lawsuit.

Your Zantac cancer lawyer can help acquire compensation for the losses you incurred as a result of your cancer. As a client, our team will work to seek the following damages for you:

  • Medical expenses resulting from injuries
  • Future medical expenses resulting from the injuries
  • Pain and suffering, both physical and mental, caused by the injuries, treatment, and recovery period
  • Wage loss, loss of earning capacity
  • Other costs associated with our injuries
  • Loss of enjoyment of life resulting from damages
  • Loss of life
  • Punitive damages against the manufacturer

 

Do I Qualify For the Zantac Class-Action Lawsuit?

If you are able to prove that you purchased Zantac consistently to treat heartburn, you may qualify for the Zantac class-action lawsuit.

A class-action lawsuit can help those affected by NDMA levels in ranitidine. A successful class-action lawsuit can help those who used Zantac get back the money they spent on the medication while making a stronger litigation case against manufacturers. This can help ensure stronger future consumer protections, updated labeling, and recalls of drugs with adverse levels of NDMA.

 

TorHoerman Law, Experienced Zantac Lawyer

At TorHoerman Law, our team of personal injury attorneys is available any time to discuss your Zantac lawsuit. We offer free no-obligation case consultations for all potential clients. Our services are based on contingency fees, so we never charge our clients a dime until they have received compensation first.

Contact TorHoerman Law to talk to a Zantac lawyer and learn about your legal options, including filing a Zantac cancer lawsuit.

More than $4 Billion Awarded in verdicts & negotiated settlements

SCROLL FOR MORE

$1.5
MILLION

CAR ACCIDENT

PERSONAL INJURY

$650
MILLION

PRADAXA INJURY LAWSUIT

PHARMACEUTICAL PRODUCT

$4
MILLION

TRAUMATIC BRAIN INJURY AT DAYCARE

PERSONAL INJURY

$2.4
BILLION

ACTOS INJURY LAWSUIT

PHARMACEUTICAL PRODUCT

$300
THOUSAND

SLIP AND FALL

PERSONAL INJURY

$1.5
BILLION

SYNGENTA CORN LAWSUIT

CHEMICAL EXPOSURE

$20
MILLION

TOXIC TORT INJURY

CHEMICAL EXPOSURE

$103.8
MILLION

COX-2 INHIBITORS INJURY

PHARMACEUTICAL PRODUCT

Client Reviews

SCROLL FOR MORE

They helped my elderly uncle receive compensation for the loss of his wife who was administered a dangerous drug. He consulted with this firm because of my personal recommendation and was very pleased with the compassion, attention to detail and response he received. Definitely recommend this firm for their 5 star service.

When I wanted to join the Xarelto class action lawsuit, I chose TorrHoerman Law from a search of a dozen or so law firm websites. I was impressed with the clarity of the information they presented. I gave them a call, and was again impressed, this time with the quality of our interactions.

TorHoerman Law is an awesome firm to represent anyone that has been involved in a case that someone has stated that it's too difficult to win. The entire firm makes you feel like you’re part of the family, Tor, Eric, Jake, Kristie, Chad, Tyler, Kathy and Steven are the best at what they do.

When I wanted to join the Xarelto class action lawsuit, I chose TorrHoerman Law from a search of a dozen or so law firm websites. I was impressed with the clarity of the information they presented. I gave them a call, and was again impressed, this time with the quality of our interactions.

When I wanted to join the Xarelto class action lawsuit, I chose TorrHoerman Law from a search of a dozen or so law firm websites. I was impressed with the clarity of the information they presented. I gave them a call, and was again impressed, this time with the quality of our interactions.

THANK YOU FOR YOUR MESSAGE

One of our associates will follow up with you shortly